Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement

  title={Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement},
  author={Christoph Lange and Ibrahim Abubakar and Jan-Willem C Alffenaar and Graham Henry Bothamley and Jos{\'e} A. Caminero and Anna Cristina Calçada Carvalho and Kwok Chiu Chang and Luigi Ruffo Codecasa and Ana Teresa Correia and Valeriu Crudu and Peter Davies and Martin John Dedicoat and Francis A. Drobniewski and Raquel Duarte and Cordula Ehlers and Connie G.M. Erkens and Delia Goletti and G. R. Guenther and Elmira Ibraim and Beate Kampmann and Līga Kuk{\vs}a and Wiel Cm de Lange and Frank van Leth and Jan van Lunzen and Alberto Matteelli and Dick Menzies and Ignacio Monedero and Elvira Richter and Sabine Ruesch-Gerdes and Andreas Sandgren and Anna Scardigli and Alena M Skrahina and Enrico M Tortoli and Grigory V. Volchenkov and Dirk Wagner and Marieke J van der Werf and Bhanu Williams and Wing-wai Yew and J. P. Zellweger and Daniela M Cirillo},
  booktitle={The European respiratory journal},
The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) substantially challenges TB control, especially in the European Region of the World Health Organization, where the highest prevalence of MDR/XDR cases is reported. The current management of patients with MDR/XDR-TB is extremely complex for medical, social and public health systems. The treatment with currently available anti-TB therapies to achieve relapse-free cure is long and undermined by a high… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 72 times over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.
79 Citations
240 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 79 extracted citations


Publications referenced by this paper.
Showing 1-10 of 240 references

Efficacy and safety of meropenem-clavulanate added to linezolidcontaining regimens in the treatment of MDR-/XDR-TB

  • S De Lorenzo, JW Alffenaar, G Sotgiu
  • Eur Respir J
  • 2013

Global tuberculosis report

  • A Skrahina, H Hurevich, A Zalutskaya
  • Geneva, Switzerland,
  • 2013

Similar Papers

Loading similar papers…